宜宾专业整容隆鼻(宜宾的做双眼皮整容医院) (今日更新中)

The village of Deerfield in northern Illinois has passed a ban on assault weapons, but it affects much more than sales and manufacturing.If the 18,000 residents of the Chicago suburb don't forfeit or secure weapons that fall under the ban by June 13th, they will be charged from 0 to ,000 a day as a penalty. 321

The Senate is expected to vote on an economic relief package this week and while it has little chance of passing the House, it is sending a very clear message to airlines: help may not be coming. United Airlines and American Airlines have both threatened thousands of their employees with layoffs if government assistance doesn't come before October 1. October 1 is the first date airlines that took bailout money from earlier this year can layoff workers under the terms set by Congress. United is looking at cutting around 16,000 employees while American is slashing around 19,000 workers. Southwest and Delta, notably, are not laying off workers after offering buyouts to many workers. For weeks, airlines and unions were holding out hope lawmakers would pass a bill after returning from their August recess. The Association of Flight Attendants took to Capitol Hill Wednesday to demand action. 906

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690

The White House has issued a new warning to CNN's Jim Acosta, saying his press pass could be revoked again at the end of the month.In response, CNN is asking the U.S. District Court for another emergency hearing."The White House is continuing to violate the First and 5th Amendments of the Constitution," the network said in a statement Sunday. "These actions threaten all journalists and news organizations. Jim Acosta and CNN will continue to report the news about the White House and the President."Last Friday CNN won a temporary restraining order, forcing the White House to restore Acosta's press access to the White House for 14 days. Judge Timothy J. Kelly ruled on Fifth Amendment grounds, saying Acosta's right to due process had been violated. He did not rule on CNN's argument about First Amendment violations.Later that same day, the White House sent Acosta a formal letter outlining a "preliminary decision" to suspend his pass again once the restraining order expires. The letter cited his conduct at President Trump's November 7 press conference.The letter was signed by two of the defendants in the suit, press secretary Sarah Sanders and deputy chief of staff for communications Bill Shine.The letter signaled that the Trump administration wants to continue fighting Acosta, despite the round one setback in court, rather than seeking an out-of-court settlement.It looked like an effort to establish a paper trail that will empower the administration to boot Acosta again at the end of the month.In a court filing on Monday, CNN's lawyers said the network and Acosta "remain hopeful" that the parties "can resolve this dispute without further court intervention."But the new letter from Shine and Sanders is an "attempt to provide retroactive due process," the lawyers said.So CNN and Acosta are seeking a hearing on a preliminary injunction "for the week of November 26, 2018, or as soon thereafter as possible," according to Monday's filing.Such an injunction could be in effect for much longer, thereby protecting Acosta's access to the White House.Lawyers were already expected to be back in court this week to discuss the timeline for further proceedings. 2186

The Salt Lake Tribune reported late Monday night that at least one person has died in a 'shots fired' incident on the University of Utah's campus. According to the university, it asked those on campus to "shelter in place" Monday night as authorities looked for the gunman, and other possible victims. Traffic was reportedly blocked off, and mass transit was shut down in the immediate vicinity of the shooting. The suspect is said to be 24-year-old Austin J. Boutain, who was wearing a coat, jeans and beanie, with a teardrop tattoo on his face. The university added that he may have been driving a forest green pick-up truck with Colorado plates.As of early Tuesday morning, he was still on the loose, and considered dangerous. 767

来源：资阳报